On ECHEMI
Home > Drugs > ACYW135 group meningococcal polysaccharide vaccine

ACYW135 group meningococcal polysaccharide vaccine

Indication

This product is only used to prevent epidemic meningitis caused by groups A, C, Y and W135 of Neisseria meningitidis.

Precautions

1. People with epilepsy, convulsions, brain diseases and a history of allergies; 2. People with kidney disease, heart disease and active tuberculosis; 3. People with acute infectious diseases and fever.

Packaging Specification

After reconstitution, each bottle contains 0.5ml, and the dose for one person each time is 0.5ml, containing 50ug each of group A, group C, group Y and group W135 polysaccharides.

Manufacturer

Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd.

  • Founded in:

    1986-12-19
  • Address:

    No. 56, Tianhe Road, Economic and Technological Development Zone, Linping District, Hangzhou City, Zhejiang Province
  • Tax NO.:

    91330000143833309Q
  • Registered Funds:

    1,066.8 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.